Introduction
The main source of morbidity in opTOF emanated from MAA. Intuitively they are related to the RA dimension.
Methods
145 consecutive opTOF >12 years old (mean 24±10 years) were evaluated by ECG 24-hour ambulatory monitoring, MR exam, echocardiography, cardiopulmonary exercise test and Amino-Terminal pro-Brain Natriuretc Peptide (NT-proBNP) blood assay. Clinical adverse events and MAA (atrial fibrillation, flutter, or atrial tachycardia) were recorded. RA dimension was assessed by summing the RA diameters on the three main axes (antero-posterior, laterolateral, supero-inferior) from a volumetric MR acquisition and compared to 68 healthy age matched subjects as control.
Results
Mean follow-up from primary repair was 23±5 years. RA was significantly dilated in comparison with normal subjects (173 mm ±28 vs 150±20 p<0.01). 22 patients (15%) presented MAA, that represent 65% of all adverse events. At logistic regression univariate analysis the following findings resulted associated with MAA: patient age (OR 1.08, 95% CI: 1.036 to 1.136, p=0.001), QRS length (OR 1.056, 95% CI: 1.029 to 1.083, p=0.01), NT-proBNP: (OR 1.004, 95% CI: 1.002 to 1.007, p<0.01), RV end-diastolic indexed volume (OR 1.022, 95% CI: 1.010 to 1.034, p<0.01), RA diameters sum (OR 1.058, 95% CI: 1.032 to 1.085, p<0.01), tricuspid regurgitation (OR 3.4, 95% CI: 1.323 to 9.128, p=0.01). At logistic multivariate analysis RA dimension resulted an independent predictor factor for MAA: (OR 1.04, 95% CI: 1.019 to 1.061, p< 0.01). At ROC curve analysis a RA diameter sum > 198 mm distinguishes pts with MAA (specificity 94%, sensitivity 65%; AUC 0.81; 95% CI 0.73-0.875).
Conclusion
In opTOF MAA are correlated to age. Tricuspid regurgitation and RA dimension are important risk factors as well. Laboratory follow-up of opTOF should also take into account the RA dimension and MRI is the tool of choice. In this paper we propose a new method for the RA measurement. In opTOF a RA diameters sum >198 mm indicates a high probability of MAA.
